Walleye Trading LLC Travere Therapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$23.61 - $30.6 $186,519 - $241,740	-7,900 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$24.34 - $31.17 $255,570 - $327,285	-10,500 Reduced 57.07%	7,900 $245,000
Q3 2021 Nov 15, 2021	BUY	$12.98 - $25.03 $238,832 - $460,552	18,400 New	18,400 $446,000
Q1 2021 May 17, 2021	SELL	$23.37 - $31.77 $296,799 - $403,479	-12,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$19.17 - $27.87 $243,459 - $353,949	12,700 New	12,700 $346,000

213

94.1M

1.2M

778K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.41B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.